Given the absence of a proven effective treatment for ALI and subsequent lung fibrogenesis, Src and Smad3 inhibition might provide an attractive target in the deteriorating process of patients with ARDS. This evidence concerns the gene SMAD3 and acute respiratory distress syndrome.